28 related articles for article (PubMed ID: 17094427)
1. Cryotherapy for liver metastases.
Bala MM; Riemsma RP; Wolff R; Pedziwiatr M; Mitus JW; Storman D; Swierz MJ; Kleijnen J
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD009058. PubMed ID: 31291464
[TBL] [Abstract][Full Text] [Related]
2. Intravital microscopic research of microembolization with degradable starch microspheres.
Ebert M; Ebert J; Berger G
J Drug Deliv; 2013; 2013():242060. PubMed ID: 24324891
[TBL] [Abstract][Full Text] [Related]
3. Unresectable colorectal liver metastases: the safety and efficacy of conversion therapy using hepatic arterial infusion immunochemotherapy with 5-fluorouracil and polyethylene glycol-interferon α-2a.
Nakai T; Okuno K; Kitaguchi H; Ishikawa H; Yamasaki M
World J Surg; 2013 Aug; 37(8):1919-26. PubMed ID: 23564218
[TBL] [Abstract][Full Text] [Related]
4. Hepatic arterial infusion (HAI) with PEGylated liposomes containing 5-FU improves tumor control of liver metastases in a rat model.
Pohlen U; Buhr HJ; Berger G; Ritz JP; Holmer C
Invest New Drugs; 2012 Jun; 30(3):927-35. PubMed ID: 21360049
[TBL] [Abstract][Full Text] [Related]
5. [Update on chemoinfusion and chemoembolization treatments].
Lubienski A; Simon M; Lubienski K; Gellissen J; Hoffmann RT; Jakobs TF; Helmberger T
Radiologe; 2007 Dec; 47(12):1097-106, 1108. PubMed ID: 17992500
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional networks in plasmacytoid dendritic cells stimulated with synthetic TLR 7 agonists.
Birmachu W; Gleason RM; Bulbulian BJ; Riter CL; Vasilakos JP; Lipson KE; Nikolsky Y
BMC Immunol; 2007 Oct; 8():26. PubMed ID: 17935622
[TBL] [Abstract][Full Text] [Related]
7. Biochemical modulation of 5-fluorouracil by folinic acid or alpha-interferon with and without other cytostatic drugs in gastric, esophageal, and pancreatic cancer.
Wilke H; Stahl M; Schmoll HJ; Preusser P; Fink U; Meyer HJ; Achterrath W; Knipp H; Köhne-Wömpner CH; Harstrick A
Semin Oncol; 1992 Apr; 19(2 Suppl 3):215-9. PubMed ID: 1557651
[TBL] [Abstract][Full Text] [Related]
8. Multicenter pilot study of 5-fluorouracil, folinic acid, interferon alpha-2b and degradable starch microspheres via hepatic arterial infusion in patients with nonresectable colorectal liver metastases.
Pohlen U; Mansmann U; Berger G; Germer CT; Gallkowski U; Boese-Landgraf J; Buhr HJ
Anticancer Res; 2004; 24(5B):3275-82. PubMed ID: 15510623
[TBL] [Abstract][Full Text] [Related]
9. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG
Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alfa-2b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin.
Patt YZ; Hoque A; Lozano R; Pozdur R; Chase J; Carrasco H; Chuang V; Delpassand ES; Ellis L; Curley S; Roh M; Jones DV
J Clin Oncol; 1997 Apr; 15(4):1432-8. PubMed ID: 9193336
[TBL] [Abstract][Full Text] [Related]
11. Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases.
Link KH; Pillasch J; Formentini A; Sunelaitis E; Leder G; Safi F; Kornmann M; Beger HG
Eur J Surg Oncol; 1999 Aug; 25(4):381-8. PubMed ID: 10419708
[TBL] [Abstract][Full Text] [Related]
12. Combined systemic chronotherapy and hepatic artery infusion for the treatment of metastatic colorectal cancer confined to the liver.
Shimonov M; Hayat H; Chaitchik S; Brener J; Schachter P; Czerniak A
Chemotherapy; 2005 May; 51(2-3):111-5. PubMed ID: 15886466
[TBL] [Abstract][Full Text] [Related]
13. Hepatic arterial infusion (HAI). Comparison of 5-fluorouracil, folinic acid, interferon alpha-2b and degradable starch microspheres versus 5-fluorouracil and folinic acid in patients with non-resectable colorectal liver metastases.
Pohlen U; Rieger H; Mansmann U; Berger G; Buhr HJ
Anticancer Res; 2006; 26(5B):3957-64. PubMed ID: 17094427
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
